acridines and jp-1302
acridines has been researched along with jp-1302 in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Tricklebank, MD | 1 |
| Engström, M; Haapalinna, A; Höglund, I; Lehtimäki, J; Sallinen, J; Savola, JM; Sirviö, J; Virtanen, R; Wurster, S | 1 |
| Fagerholm, V; Haaparanta, M; Hietala, J; Nyman, L; Rokka, J; Sallinen, J; Tiihonen, J; Tupala, E | 1 |
| Imaki, J; Mae, Y; Ohno, Y; Shimizu, S | 1 |
| Afonso, J; Moura, E; Pinto, CE; Serrão, MP; Vieira-Coelho, MA | 1 |
| Boyce, CW; Corboz, MR; McCormick, KD; McLeod, RL; Mingo, GG; Mukhopadhyay, G; Salisbury, BG | 1 |
| Akiyama, M; Fukumura, T; Hatori, A; Kawamura, K; Kumata, K; Nengaki, N; Takei, M; Wakizaka, H; Yamasaki, T; Yanamoto, K; Yui, J; Zhang, MR | 1 |
| Afonso, J; Kozmus, CE; Moura, E; Serrão, MP; Silva, E; Vieira-Coelho, MA | 1 |
| Chapman, H; Haapalinna, A; Holappa, J; Koivisto, A; Kuokkanen, K; Lehtimäki, J; Mijatovic, J; Piepponen, P; Sallinen, J; Sirviö, J; Tanila, H; Virtanen, R | 1 |
| Khisamieva, LI; Zefirov, AL; Zefirov, TL; Ziyatdinova, NI | 2 |
| Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Tanba, T; Terada, T; Tojo, A; Tsutsui, H; Yamagata, M; Yoshida, S; Yukimura, T | 1 |
| Endo, S; Kozawa, M; Murakami, H; Muto, M; Tadano, T; Tan-No, K; Tsuchiya, M; Yaoita, F | 1 |
| Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yukimura, T | 1 |
| Hayashi, K; Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yoneda, K; Yukimura, T | 1 |
Other Studies
15 other study(ies) available for acridines and jp-1302
| Article | Year |
|---|---|
JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain.
Topics: Acridines; Adrenergic alpha-Antagonists; Animals; Animals, Genetically Modified; Brain Chemistry; Mice; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2007 |
Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Topics: Acridines; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Binding, Competitive; Cell Membrane; Central Nervous System; Dexmedetomidine; Dose-Response Relationship, Drug; Electric Stimulation; Humans; Hypothermia; In Vitro Techniques; Male; Mice; Motor Activity; Muscle Contraction; Muscle, Smooth; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reflex, Startle; Swimming; Vas Deferens | 2007 |
Autoradiographic characterization of alpha(2C)-adrenoceptors in the human striatum.
Topics: Acridines; Adrenergic alpha-Antagonists; Animals; Autoradiography; Binding Sites; Binding, Competitive; Catecholamines; Cerebellum; Cerebral Cortex; Corpus Striatum; Evolution, Molecular; Humans; Isoquinolines; Ligands; Male; Middle Aged; Naphthyridines; Phylogeny; Piperazines; Rats; Receptors, Adrenergic, alpha-2; Species Specificity; Tritium | 2008 |
Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antipsychotic Agents; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Hypokinesia; Imidazoles; Isoindoles; Male; Mice; Motor Activity; Piperazines; Yohimbine | 2009 |
Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biological Transport; Brain; Catechol O-Methyltransferase; Catecholamines; Cell Line, Tumor; Dopamine beta-Hydroxylase; Humans; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; Piperazines; Receptors, Adrenergic, alpha-2; Tyrosine 3-Monooxygenase; Yohimbine | 2009 |
Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat.
Topics: Acridines; Administration, Intranasal; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Blood Pressure; Cats; Dose-Response Relationship, Drug; Male; Nasal Cavity; Neurons; Piperazines; Protein Isoforms; Receptors, Adrenergic, alpha-2; Rhinitis; Rhinometry, Acoustic; Sympathetic Nervous System | 2010 |
In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography.
Topics: Acridines; Adrenergic alpha-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzofurans; Biological Transport; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Isoquinolines; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Piperazines; Quinolizines; Receptors, Adrenergic, alpha-2; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2010 |
α2C-Adrenoceptors modulate L-DOPA uptake in opossum kidney cells and in the mouse kidney.
Topics: Acridines; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Cell Line; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Kidney; Levodopa; MAP Kinase Kinase 1; Medetomidine; Mice; Mice, Knockout; Opossums; Piperazines; Receptors, Adrenergic, alpha-2; Signal Transduction; Sodium Chloride, Dietary | 2012 |
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Benzofurans; Central Nervous System; Central Nervous System Diseases; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hypothermia; Male; Mice; Neuroprotective Agents; Phencyclidine; Piperazines; Quinolizidines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2013 |
Peculiar Effects of Selective Blockade of α2-Adrenoceptor Subtypes on Cardiac Chronotropy in Newborn Rats.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Animals, Newborn; Heart; Heart Conduction System; Heart Rate; Idazoxan; Imidazoles; Myocardial Contraction; Piperazines; Rats; Receptors, Adrenergic, alpha-2; Receptors, Presynaptic; Tachycardia | 2015 |
Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Chemokine CCL2; Cytoprotection; Gene Expression Regulation; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Tumor Necrosis Factor-alpha; Yohimbine | 2016 |
Selective Blockade of α
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Animals, Outbred Strains; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Idazoxan; Imidazoles; Myocardial Contraction; Piperazines; Rats; Receptors, Adrenergic, alpha-2; Tissue Culture Techniques | 2016 |
Involvement of peripheral alpha2A adrenoceptor in the acceleration of gastrointestinal transit and abdominal visceral pain induced by intermittent deprivation of REM sleep.
Topics: Acetic Acid; Acridines; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Transit; Ileum; Imidazoles; Irritable Bowel Syndrome; Isoindoles; Male; Mice; Piperazines; Receptors, Adrenergic; Sleep Deprivation; Sleep, REM; Visceral Pain | 2018 |
Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Chemokine CCL2; Cisplatin; Disease Models, Animal; Injections, Intraperitoneal; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine | 2018 |
Post-treatment with JP-1302 protects against renal ischemia/reperfusion-induced acute kidney injury in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Urea Nitrogen; Creatinine; Cytokines; Drug Administration Schedule; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Up-Regulation | 2019 |